JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.
Skip to content
Summary
AI-generated from the abstract
This is a correction notice for a previously published article. It provides no new findings, arguments, or data.
Abstract
[This corrects the article DOI: 10.1089/psymed.2022.0002.].
Create a free account to bookmark articles, vote on relevance, generate your own syntheses, and join the discussion.
Related reading
A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression
June 30, 2022
1 citation
via OpenAlex
A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression
Psychedelic Medicine
October 28, 2022
15 citations
via OpenAlex
Corrigendum to "Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis" [Journal of affective disorders, 322 (2023), 194-204].
J Affect Disord
April 3, 2025
via PubMed
Corrigendum to “Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis”. [J. Affect. Disord., 322 (2023), 194–204]
Journal of Affective Disorders
January 5, 2024
1 citation
via OpenAlex
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
J Affect Disord
October 10, 2025
via PubMed
© 2026 Mindscape Collective
Support Our Mission
Choose your preferred way to support Mindscape Collective's work in advancing consciousness research.